Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...

Oral Hypoglycemic Agents: Glinides

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantifying sleep wake rhythms in the hospital environment with digital technologies.

NPJ digital medicine·2026

Same author

Comparing the quantitation of specialized pro-resolving mediators in plasma and serum using ELISA and LC-MS/MS.

Prostaglandins, leukotrienes, and essential fatty acids·2026

Same author

TracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes.

medRxiv : the preprint server for health sciences·2026

Same author

Depression of tryptophan may contribute to adverse effects of naproxen.

Nature communications·2026

Same author

Age and the Diurnal Oscillatory Features of the Human Chronobiome.

medRxiv : the preprint server for health sciences·2026

Same author

Concomitant COX-1 and COX-2 suppression is not sufficient to induce enteropathy associated with chronic NSAID use.

The Journal of clinical investigation·2026

Same journal

Editorial: Technologies for RNA Detection.

Bio-protocol·2026

Same journal

One-Step Affinity Purification of MarathonRT Reverse Transcriptase for RNA Sequencing Applications.

Bio-protocol·2026

Same journal

Enhanced RNA-Seq Expression Profiling and Functional Enrichment in Non-model Organisms Using Custom Annotations.

Bio-protocol·2026

Same journal

Using Combined Fluorescent In Situ Hybridization With Immunohistochemistry to Co-localize mRNA in Diverse Neuronal Cell Types.

Bio-protocol·2026

Same journal

Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq Data.

Bio-protocol·2026

Same journal

Enriching Bacteria-Specific RNA From Host Samples Before NGS With Transcript-Capture.

Bio-protocol·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

Insulin Tolerance Test and Hyperinsulinemic-Euglycemic Clamp.

Georgios K Paschos¹, Garret A FitzGerald¹

¹Pharmacology Department, University of Pennsylvania, Philadelphia, USA.

|July 23, 2016

Summary

This summary is machine-generated.

Two tests assess insulin sensitivity in mice. The hyperinsulinemic-euglycemic clamp specifically measures insulin sensitivity in the liver and other key metabolic tissues.

More Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Mar 17, 2026

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

Area of Science:

Metabolic research
Endocrinology
Animal models

Background:

Insulin resistance is a major health concern.
Accurate assessment of insulin sensitivity is crucial for metabolic research.
Mouse models are widely used to study metabolic diseases.

Purpose of the Study:

To evaluate two distinct tests for assessing insulin sensitivity in mice.
To determine the utility of the hyperinsulinemic-euglycemic clamp for measuring tissue-specific insulin sensitivity.

Main Methods:

Utilized two distinct testing methodologies to assess insulin sensitivity.
Employed the hyperinsulinemic-euglycemic clamp technique in mouse models.
Focused on evaluating insulin sensitivity in liver and other metabolically relevant tissues.

Main Results:

The study successfully evaluated two tests for in vivo insulin sensitivity.
The hyperinsulinemic-euglycemic clamp provided specific data on liver insulin sensitivity.
The clamp method also yielded insights into insulin sensitivity in other key metabolic tissues.

Conclusions:

Two validated methods exist for assessing mouse insulin sensitivity.
The hyperinsulinemic-euglycemic clamp is a valuable tool for quantifying liver and tissue-specific insulin sensitivity in vivo.